Literature DB >> 24231308

Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors.

Leonardo Pisani1, Marco Catto, Orazio Nicolotti, Giancarlo Grossi, Mario Di Braccio, Ramon Soto-Otero, Estefania Mendez-Alvarez, Angela Stefanachi, Domenico Gadaleta, Angelo Carotti.   

Abstract

The effects on the inhibition potencies of monoamine oxidase isoforms A (MAO-A) and B (MAO-B) depending upon changes in the physicochemical properties (size, shape, H-bonding, lipophilicity, etc.) of substituents at the C4 position of 2H-chromen-2-one derivatives were extensively investigated, and the results significantly added to our knowledge on this class of MAO inhibitors. All the 67 examined compounds showed high MAO-B selectivity, some of them achieving potency in the low nanomolar range. In particular, the 7-metachlorobenzyloxy-4-oxyacetamido-2H-chromen-2-one (entry 62) showed single digit nanomolar MAO-B potency (IC₅₀ = 3.1 nM) and high selectivity over the MAO-A isoform (selectivity ratio = 7244). The great variety of the investigated substituents at C4 of the 2H-chromen-2-one nucleus, combined with binding models generated from docking studies carried out on selected compounds, allowed us to shed light on the main molecular requirements for potent and selective MAO-B inhibition, highlighting the dominant role of the steric effects. Interestingly, many of the designed substituents could be metabolically related to each other (e.g., CH₃/CH₂OH/CHO/COOH; NH₂/NHCH₃, NHAc), and therefore the results obtained may help in predicting the in vivo activity of some putative metabolites of lead MAO-B inhibitors.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  4-Substituted-7-benzyloxy-2H-chromene-2-ones; Alzheimer's disease; Molecular docking; Monoamine oxidase inhibitors; Neurodegenerative diseases; Parkinson's disease; Selective MAO-B inhibitors

Mesh:

Substances:

Year:  2013        PMID: 24231308     DOI: 10.1016/j.ejmech.2013.09.034

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

Review 1.  Kinetics, mechanism, and inhibition of monoamine oxidase.

Authors:  Rona R Ramsay; Alen Albreht
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

2.  2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.

Authors:  Lesetja J Legoabe; Anél Petzer; Jacobus P Petzer
Journal:  Drug Des Devel Ther       Date:  2015-07-15       Impact factor: 4.162

Review 3.  Computer-aided Drug Design Applied to Parkinson Targets.

Authors:  Hamilton M Ishiki; Jose Maria Barbosa Filho; Marcelo S da Silva; Marcus T Scotti; Luciana Scotti
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

4.  Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation.

Authors:  Dong Wang; Ren-Yuan Hong; Mengyao Guo; Yi Liu; Nianhang Chen; Xun Li; De-Xin Kong
Journal:  Molecules       Date:  2019-11-05       Impact factor: 4.411

Review 5.  Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer's disease.

Authors:  Samina Khan Yusufzai; Mohammad Shaheen Khan; Othman Sulaiman; Hasnah Osman; Dalily Nabilah Lamjin
Journal:  Chem Cent J       Date:  2018-12-04       Impact factor: 4.215

Review 6.  Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds.

Authors:  Angela Stefanachi; Francesco Leonetti; Leonardo Pisani; Marco Catto; Angelo Carotti
Journal:  Molecules       Date:  2018-01-27       Impact factor: 4.411

7.  Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2H-Chromen-2-ones.

Authors:  Mariagrazia Rullo; Marco Catto; Antonio Carrieri; Modesto de Candia; Cosimo Damiano Altomare; Leonardo Pisani
Journal:  Molecules       Date:  2019-12-09       Impact factor: 4.411

8.  Bcr-Abl Allosteric Inhibitors: Where We Are and Where We Are Going to.

Authors:  Francesca Carofiglio; Daniela Trisciuzzi; Nicola Gambacorta; Francesco Leonetti; Angela Stefanachi; Orazio Nicolotti
Journal:  Molecules       Date:  2020-09-14       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.